HIV Prevention Interventions for Adolescents in Brooklyn
This paper reviews five evidence-based HIV prevention intervention programs—PrEP (Pre-Exposure Prophylaxis), the CHAT intervention, CONNECT 2, the Healthy Living Project (HLP), and Cognitive-Behavioral STD/HIV Risk-Reduction—and evaluates their effectiveness across diverse at-risk populations. Drawing on study findings, statistical outcomes, and identified program limitations, the paper proposes a framework for reducing HIV incidence among adolescents in Brooklyn. It also examines a structural intervention model from Malawi in which conditional and unconditional cash transfers to young women were studied as a means of reducing HIV risk, and applies logic model thinking to guide future program design and evaluation.
- Introduction and HIV Overview: HIV defined; intervention study rationale introduced
- PrEP: Pre-Exposure Prophylaxis: Daily Truvada prophylaxis reduces HIV risk
- CHAT Intervention: Peer communication model reduces risky sexual behavior
- CONNECT 2: Couple-Based HIV Risk Reduction: Couple-focused program cuts unprotected sex rates
- Healthy Living Project (HLP): Three-module program for HIV-positive individuals assessed
- Cognitive-Behavioral STD/HIV Risk-Reduction Intervention: Behavioral intervention reduces STD/HIV risk at clinics
- Structural Intervention and Proposed Framework for Brooklyn: Cash transfer model and logic model for Brooklyn youth
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Systematically reviews five distinct intervention programs, presenting each with its goals, target population, methods, and quantitative findings before drawing broader conclusions.
- Uses precise statistical data (odds ratios, confidence intervals, p-values) to support claims, lending empirical weight to program evaluations.
- Critically assesses program limitations—particularly the HLP study—demonstrating analytical thinking beyond simple summary.
Key academic technique demonstrated
The paper demonstrates comparative program evaluation: each intervention is described using a consistent organizational template (goals, population, findings, limitations), enabling the reader to judge relative effectiveness across programs. This scaffolded comparison is then used to justify a new proposed framework, illustrating how a literature review can transition into policy or program design recommendations.
Structure breakdown
The paper opens with a brief conceptual introduction defining HIV and the purpose of intervention studies. Five numbered intervention sections follow, each self-contained but contributing to a cumulative evidence base. A final section introduces a structural intervention model from Malawi and applies logic model reasoning to propose a Brooklyn-specific HIV prevention strategy. References are drawn from CDC program documents, peer-reviewed articles, and public health databases.
Introduction and HIV Overview
Intervention studies are an approach to addressing health conditions that is being applied globally. For any given community, intervention studies may succeed in reducing the burden of a health issue, or they may prove insufficient. One medical condition that has been the subject of numerous intervention studies is HIV. Results have ranged from meaningful success to relative failure. In this paper, five intervention studies for HIV are reviewed. From these data, a new method to decrease HIV's effects upon adolescents in Brooklyn is proposed.
Defining HIV
The human immunodeficiency virus (HIV) is a retrovirus that can be transmitted from one person to another via contact with broken skin, eyes, or vaginal and/or anal tissue. The process of viral replication includes reproduction, during which structural mutations may occur. Unfortunately, each of these mutations may confer new resistance to drug therapies that were formerly efficacious. Present HIV therapy involves pharmaceutical combinations that function by considerably slowing the organism's ability to develop resistance.
PrEP: Pre-Exposure Prophylaxis
The intent of the PrEP intervention for HIV prevention is to offer those at high risk a daily prophylactic medication. Participants are given Truvada, a pharmaceutical combination of emtricitabine and tenofovir — two drugs commonly used in HIV treatment. Use of Truvada can help prevent permanent HIV infection for those at risk due to sexual activity or injection drug use.
Even for high-risk individuals, consistent use of Truvada within the PrEP intervention has been shown to produce a 92% decrease in HIV risk. However, failure to take the drug consistently makes it far less effective. While PrEP can be a powerful tool against HIV — particularly when combined with condoms and other prevention methods — it is only effective with the consent and appropriate behavior of the at-risk individual. Basic requirements for PrEP include a daily commitment to taking the medication and an agreement to have a follow-up visit with a healthcare provider every three months.
The following findings were reported across the major PrEP intervention studies:
- A 49% reduction in risk of HIV infection was observed among injection drug users who took tenofovir once daily. A 74% decreased risk was observed among participants whose blood levels indicated they were taking tenofovir appropriately (Bangkok Tenofovir Study).
- Bisexual and gay men given PrEP had a 44% lower probability of becoming HIV-infected than those receiving a placebo. A 92% decrease in risk was observed for men who consistently took the pill (iPrEx Study).
- Among HIV-discordant couples, those receiving PrEP had a 75% lower likelihood of infection than those receiving the placebo. PrEP decreased the risk of HIV infection by as much as 90% for those with detectable blood levels of the drug (Partners PrEP Study).
- A 62% reduction in HIV risk was observed for heterosexually active women and men following PrEP protocols. Participants who became infected were found to have lower blood levels of the pharmaceutical than those who did not (TDF2 Study).
No significant health safety concerns or toxicity were reported for daily oral PrEP use. Minor side effects such as loss of appetite and upset stomach were reported during initial use; however, these generally resolved after the initial period and did not recur.
Create your account
Always verify citation format against your institution’s current style guide requirements.